A blood test could help identify men with advanced prostate cancer most likely to benefit from targeted radiotherapy
A blood test could help identify men with advanced prostate cancer who are more likely to experience longer disease control following targeted radiotherapy, according to research led by The Royal Marsden NHS Foundation Trust, The Institute of Cancer Research, London and University College London. The findings are published in the journal JAMA Network Open.
We haven't written up this one. Medical Xpress has the full story — the link below goes straight to it.
